Who owns Annovis Bio Inc?
- Ticker: ANVS
- CUSIP Number: 03615a108
Tip: Access positions for across all investors
Analyze quarterly positions in Annovis Bio with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Annovis Bio stock
Who bought or sold Annovis Bio Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| LMR Partners | 831k | $9.9M | 100% | Mar 2024 |
|
| Ikarian Capital | 502k | $6.0M | 14662% | Mar 2024 |
|
| Susquehanna International | 426k | $5.1M | 100% | Mar 2024 |
|
| Vanguard Group | 358k | $4.3M | 6% | Mar 2024 |
|
| Adage Capital Partners GP | 250k | $3.0M | -17% | Mar 2024 |
|
| Citadel Advisors | 205k | $2.4M | 257% | Mar 2024 |
|
| Caption Management | 157k | $1.9M | 100% | Mar 2024 |
|
| Boothbay Fund Management | 134k | $1.6M | 100% | Mar 2024 |
|
| Gts Securities | 113k | $1.3M | 878% | Mar 2024 |
|
| BlackRock | 98k | $1.2M | 1% | Mar 2024 |
|
| Belvedere Trading | 74k | $878k | 100% | Mar 2024 |
|
| Geode Capital Management | 71k | $843k | 26% | Mar 2024 |
|
| HAP Trading | 54k | $198k | 100% | Mar 2024 |
|
| Wescott Financial Advisory Group | 42k | $495k | 0% | Mar 2024 |
|
| Redmond Asset Management | 36k | $430k | 6% | Mar 2024 |
|
| Sterling Investment Advisors | 34k | $409k | 0% | Mar 2024 |
|
| Bridgeway Capital Management | 34k | $400k | 42% | Mar 2024 |
|
| Modera Wealth Management | 31k | $363k | 0% | Mar 2024 |
|
| Squarepoint Ops | 25k | $298k | 100% | Mar 2024 |
|
| Cutler | 25k | $35k | 624% | Mar 2024 |
|
| Northern Trust | 24k | $289k | 138% | Mar 2024 |
|
| Merit Financial Group | 22k | $115k | 0% | Mar 2024 |
|
| Bank of New York Mellon | 19k | $227k | -8% | Mar 2024 |
|
| Spears Abacus Advisors | 15k | $179k | 100% | Mar 2024 |
|
| Greenwich Wealth Management | 13k | $150k | 22% | Mar 2024 |
|
| Sontag Advisory | 10k | $119k | -9% | Mar 2024 |
|
| Peter B. Cannell & Co | 10k | $187k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 8.8k | $105k | 0% | Mar 2024 |
|
| Morgan Stanley | 7.2k | $85k | 399% | Mar 2024 |
|
| Bank of America Corporation | 5.5k | $66k | 69% | Mar 2024 |
|
| Tower Research Capital | 4.8k | $57k | 647% | Mar 2024 |
|
| Quest Partners | 3.3k | $40k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 1.2k | $14k | 0% | Mar 2024 |
|
| UBS Group | 600.00 | $7.1k | 0% | Mar 2024 |
|
| FNY Investment Advisers | 405.00 | $4.1k | -32% | Mar 2024 |
|
| Game Plan Financial Advisors | 200.00 | $2.4k | 0% | Mar 2024 |
|
| YHB Investment Advisors | 85.00 | $1.0k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 4.00 | $0 | -90% | Mar 2024 |
|
Who sold out of Annovis Bio?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Marshall Wace | Dec 2023 | 33k | $609k |
| Two Sigma Securities | Dec 2023 | 12k | $230k |
| Jane Street | Dec 2023 | 12k | $224k |
| Citigroup | Dec 2023 | 11k | $209k |
| Dimensional Fund Advisors | Dec 2023 | 11k | $208k |
| Private Trust Co Na | Dec 2023 | 3.0k | $56k |
| Jpmorgan Chase & Co | Dec 2023 | 152.00 | $2.8k |
| Coppell Advisory Solutions | Sep 2023 | 11.00 | $998.000300 |